Milvexian

Generic Name: Milvexian

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₈H_₂₃Cl_₂F_₂N_₉O_₂

CAS Number: 1802425-99-5

Unique Ingredient Identifier: 0W79NDQ608

Background: Milvexian is under investigation in clinical trial NCT03766581 (A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel).

Associated Conditions: -

Associated Therapies: -

Clinical Trials

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

Phase 3

Recruiting

Conditions: Atrial Fibrillation

Interventions: Drug: Apixaban
Drug: Milvexian
Drug: Placebo
Drug: Apixaban Placebo

First Posted Date: 2023-03-07

Last Posted Date: 2025-01-10

Lead Sponsor: Janssen Research & Development, LLC

Target Recruit Count: 20000

Registration Number: NCT05757869

Locations: 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
🇺🇸
Holy Name Medical Center, Teaneck, New Jersey, United States
🇦🇷
CIDIM-Centro Integral de Diagnostico por Imagenes Marchegiani, Cordoba, Argentina

and more 1022 locations

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

Phase 3

Recruiting

Conditions: Acute Coronary Syndrome

Interventions: Drug: Milvexian
Other: Placebo

First Posted Date: 2023-03-06

Last Posted Date: 2025-01-10

Lead Sponsor: Janssen Research & Development, LLC

Target Recruit Count: 16000

Registration Number: NCT05754957

Locations: 🇺🇸
Northwest Heart Clinical Research, LLC., Tomball, Texas, United States
🇮🇳
Lisie Hospital, Cochin, India
🇮🇳
Rabindranath Tagore International Institute of Cardiac Sciences, Kolkata, India

and more 908 locations

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

Phase 3

Recruiting

Conditions: Ischemic Stroke; Ischemic Attack, Transient

Interventions: Drug: Placebo
Drug: Milvexian

First Posted Date: 2023-01-27

Last Posted Date: 2025-01-10

Lead Sponsor: Janssen Research & Development, LLC

Target Recruit Count: 15000

Registration Number: NCT05702034

Locations: 🇺🇸
Neurology Center of North Orange County, Fullerton, California, United States
🇺🇸
Mission Hospital Regional Medical Center, Mission Viejo, California, United States
🇺🇸
McGovern Medical School UT Physicians Neurosurgery Texas Medical Center, Houston, Texas, United States

and more 793 locations

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy